The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma What is a 503B outsourcing facility, and why are so many of them uninspected by FDA? Partnership for Safe Medicines Pharmacy Purchasing & Products Magazine Empower 503B Outsourcing Facility Serving Retail Pharmacies Industry Update: Interim 503A and 503B Bulks Lists New Revisions